Tactogen

Growth Stage

Developing new MDMA-like medicines for effective prescription mental wellness

Overview

Raised to Date: Raised: $94,542

Total Commitments ($USD)

Platform

Wefunder

Start Date

11/11/2022

Close Date

01/31/2023

Min. Goal

$50,000

Max. Goal

$5,000,000

Min. Investment

$100

Security Type

SAFE

Series

Seed

Funding Type

RegCF

Valuation Cap

$80,000,000

Discount Rate

15%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

02/01/2023

Days Remaining
Funded
% of Min. Goal

189%

% of Max. Goal

2%

Likelihood of Max
Funded
Avg. Daily Raise

$1,167

# of Investors

165

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

Palo Alto, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

Tactogen, with a valuation of $80 million, is raising funds on Wefunder. The company is developing entactogen molecules for effective prescription mental health. Entactogens are MDMA-like molecules that help people embody a better version of themselves and let them keep their fears and self-criticism aside to think clearly about their lives. The aim of Tactogen is to bring the emotional benefits of MDMA to people while warding off their unwanted and off-target effects. Matthew Baggott founded Tactogen in February 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for safety and toxicity studies for leading molecules, Phase 1 clinical trial development, and community initiatives.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,483,543

$-428,556

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,784,371

$733,443

Accounts Receivable

$8,958

$0

Total Assets

$1,799,821

$743,111

Short-Term Debt

$136,981

$55,689

Long-Term Debt

$0

$0

Total Liabilities

$136,981

$55,689

Financials as of: 11/11/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Tactogen on Wefunder 2022
$
Platform: Wefunder
Security Type: SAFE
Valuation: $80,000,000

Follow company

Follow Tactogen on Wefunder 2022
View on Wefunder (Closed)